trial

Discriminant Validity of the Multiple Errands Test in Schizophrenia

NCTId NCT02782091
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 120 (actual)
Sponsored by Assistance Publique - Hôpitaux de Paris
Primary completion 2020-01-21
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
120 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2016-06-16
Primary completion
2020-01-21
Eligibility
ALL · 18 Years · 50 Years

Interventions & indications

Drugs
Multiple Errands Test (MET)

Sponsors

Assistance Publique - Hôpitaux de ParisLead Sponsor

Investigators

1
Franck SCHURHOFF, Prof, MD.Principal Investigator

Sites

1 total
Créteil, France

Facts & assertions

4 sourced
Enrollment
120
Phase
NA
Primary Completion Date
2020-01-21
Status
COMPLETED
relationships
The graph out of here
drug
Multiple Errands Test (MET)
drug
lead_sponsor
Assistance Publique - Hôpitaux de Paris
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Franck SCHURHOFF, Prof, MD.
person